15th Expert Committee on the Selection and Use of Essential Medicines

 

Other correspondence related to medicines

 

  • Section 06.04.02.00 - Antiretrovirals (06.04.02.03 - Protease inhibitors): Proposal for addition to the WHO EML of the formulation of  lopinavir + ritonavir (LPV/r) tablet, 200 mg + 50 mg

  • Section 06.04.02.00 - Antiretrovirals (06.04.02.03 - Protease inhibitors): Proposal for addition of the formulation of saquinavir (SQV) 500mg tablets

  • Section 06.05.02.00 - Antileishmaniasis medicines: Support for including miltefosine on the EML

 

 

Back to the EML Expert Committee Resources Menu

See also the Essential Medicines Library

 

Last update:23-Feb-2007